Improving access to surgery for African-Americans with gastrointestinal cancers in the Deep South

Who could benefit from this research

What this research studies

This research aims to address the disparities in surgical care for African-Americans suffering from gastrointestinal cancers, such as colorectal, pancreatic, and esophageal cancers, particularly in Alabama and Mississippi. The study will identify gaps in surgical care by surveying patients and reviewing medical records to understand the differences in treatment received by African-Americans compared to white patients. By implementing effective models like lay navigation and Enhanced Recovery After Surgery (ERAS), the research seeks to improve access to timely surgical interventions and enhance the quality of care provided. The ultimate goal is to eliminate racial disparities in surgical outcomes for these patients.

Why it matters

Where this research is happening

• University of Alabama at Birmingham
  Birmingham, United States Active

Researchers

• Principal investigator: Pisu, Maria — University of Alabama at Birmingham
• Study coordinator: Pisu, Maria

Related research

Other NIH-funded projects on the same topics.

• Bacterial biosensors to detect and help prevent GI cancers

  A team is building living bacterial sensors that could detect colorectal and pancreatic tumors inside the gut and give a clear diagnostic signal.

  NIH research University of California, San Diego · La Jolla, United States · NIH-11532955

• Gastrointestinal cancers: how stem cells and their environment shape cancer growth

  A research project at Columbia University Health Sciences studies how stomach, esophagus, and other GI cancers start and evolve by looking at stem cells, nerve signals, and the surrounding tissue.

  NIH research Columbia University Health Sciences · New York, United States · NIH-11391403

• Bacterial biosensors to help detect GI cancers early

  A living bacterial sensor is being developed to spot colorectal and pancreatic cancers early inside the GI tract and give a readable diagnostic output.

  NIH research University of California, San Diego · La Jolla, United States · NIH-11389304

• DPYD Genetic Testing in Community Cancer Care to Prevent Fluoropyrimidine Toxicity

  A community-based study will test whether offering DPYD genetic testing before chemotherapy with FP drugs reduces severe side effects and hospitalizations for people with GI cancers.

  NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11340343

• Cell signaling and gene regulation in liver and gastrointestinal cancers

  Researchers are looking at how signaling proteins and gene-regulating enzymes like SIRT6 interact to explain why fatty liver disease can turn into liver cancer.

  NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11308736

• Understanding and Improving Chemoradiation Response in Esophagogastric and Pancreatic Cancer

  This grant aims to learn why esophagogastric and pancreatic cancers resist standard chemoradiation and to use that knowledge to guide better, biomarker-driven treatments.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11263056

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.